此外,H.C. Wainwright分析师期待GH001在治疗难治性抑郁症方面的关键Phase 3项目可能于2026年上半年启动。他们强调了该药物在治疗TRD方面已显示出的疗效和持久性。分析师还指出,GH Research正在探索GH001的其他适应症,包括产后抑郁症(PPD)和双相II型障碍(BP-II),这可能扩大该药物的市场机会。
6 小时
Soap Opera Digest on MSNThe Best And Worst On BTG, B&B, DAYS, And GH The Week Of March 10-14Willow (Katelyn MacMullen) played with the truth on GH, Johnny (Carson Boatman) threw it in his father's face on DAYS and Li ...
Tuesday, GH Research PLC (NASDAQ:GHRS) received a reiterated Buy rating and $40.00 price target from H.C. Wainwright, representing significant upside potential for the $936 million market cap company.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果